3
Views
17
CrossRef citations to date
0
Altmetric
HYPERTENSION AND COSTS

The costs of treating hypertension

What are the long-term realities of cost containment and pharmacoeconomics?

Pages 241-252 | Published online: 05 Dec 2017

References

  • The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153(2): 154–83
  • American Heart Association. Heart and stroke facts. Dallas: AHA, 1994: 23
  • Edelson JT, Weinstein MC, Tosteson AN, et al. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990; 263(3): 407–13
  • Manolio TA, Cutler JA, Furberg CD, et al. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med 1995; 155(8): 829–37
  • Reif MC, Carter VL. The retail cost of anti- hypertensive therapy: physician and patient as educated consumers. Am J Hypertens 1994; 7(7 Pt l): 571–5
  • Kaplan NM. An examination of the retail cost of antihypertensive therapy. (Editorial) Am J Hypertens 1994; 7(7 Pt l): 675–6
  • Prisant LM, Carr AA, Bottini PB, et al. Sexual dysfunction with antihypertensive drugs. Arch Intern Med 1994; 154(7): 730–6
  • Hilleman DE, Mohiuddin SM, Lucas BD Jr, et al. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension. Clin Ther 1994; 16(1): 88–102
  • Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325(15): 1072–7
  • Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med 1994; 331(10): 650–5
  • Dustan HP, Caplan LR, Curry CL, et al. Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent. Circulation 1992; 85(2): 849–60
  • Hendel es L, Hochhaus G, Kazerounian S. Generic and alternative brand-name pharmaceutical equivalents: select with caution. Am J Hosp Pharm 1993; 50 (2): 323–9 [Erratum, Am J Hosp Pharm 1993; 50(5): 913]
  • Smalley WE, Griffin MR, Fought RL, et al. Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients. N Engl J Med 1995: 332(24): 1612–7
  • Moexipril: another ACE inhibitor for hypertension. Med Lett Drugs Ther 1995; 37(956): 75–6
  • Drugs for hypertension. Med Len Drugs Ther 1995; 37(949): 45–50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.